{
    "clinical_study": {
        "@rank": "82149", 
        "acronym": "\u03b2-SPECIFIC 4Pa", 
        "arm_group": [
            {
                "arm_group_label": "Canakinumab - Cohort 1, 2mg", 
                "arm_group_type": "Experimental", 
                "description": "2 mg/kg q4wk (followed by taper to 1 mg/kg q4wk and drug discontinuation if appropriate)"
            }, 
            {
                "arm_group_label": "Canakinumab - Cohort 1, 4mg", 
                "arm_group_type": "Experimental", 
                "description": "4 mg/kg q8wk (followed by taper to 4 mg/kg q12wk and drug discontinuation if appropriate)"
            }, 
            {
                "arm_group_label": "Canakinumab - Cohort 2, 2mg", 
                "arm_group_type": "Experimental", 
                "description": "2 mg/kg q4wk (followed by taper to 1 mg/kg q4wk and drug discontinuation if appropriate)"
            }, 
            {
                "arm_group_label": "Canakinumab - Cohort 2, 4mg", 
                "arm_group_type": "Experimental", 
                "description": "4 mg/kg q8wk (followed by taper to 4 mg/kg q12wk and drug discontinuation if appropriate)"
            }, 
            {
                "arm_group_label": "Cohort 2 - canakinumab dose reduction", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Cohort 1 - canakinumab dose reduction", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "This two-part open-label, multi-arm, non-comparative study will collect long-term safety,\n      efficacy and tolerability data from patients who were responsive to canakinumab from study\n      CACZ885G2301E1 (Cohort 1), and from patients who are treatment na\u00efve to canakinumab (Cohort\n      2). In addition, the effect of inactivated vaccines in an SJIA patient population will be\n      assessed for the development of adequate (protective) antibody levels following immunization\n      according to respective local vaccination guidelines.\n\n      Study Part I:\n\n      All patients will be treated with canakinumab 4 mg/kg every 4 weeks (or 2 mg/kg every 4\n      weeks for Cohort 1 patients who are receiving that dose in CACZ885G2301E1) until study end\n      unless discontinuation occurs, or until they qualify for Part II of the study.\n\n      Study Part II:\n\n      Patients who are eligible will be randomized to receive canakinumab at a reduced dose or\n      prolonged dose interval (see requirements for dose reduction/dose interval prolongation\n      below).\n\n      Patients in Cohort 1 receiving 2 mg/kg q4wk in CACZ885G2301E1 will not be randomized but\n      will be part of the treatment arm canakinumab dose reduction if they are eligible."
        }, 
        "brief_title": "An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)", 
        "condition": "Systemic Juvenile Idiopathic Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Juvenile Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Key inclusion criteria:\n\n        Cohort 1:\n\n        1. All patients currently enrolled in study CACZ885G2301E1, including patients who\n        discontinued canakinumab therapy for inactive disease in CACZ885G2301E1 as per physician\n        discretion and who are now currently in a flare and require canakinumab therapy again\n\n        Cohort 2:\n\n          1. Male and female patients aged \u2265 2 to < 20 years at the time of the screening visit\n\n          2. Confirmed diagnosis of SJIA as per ILAR definition that must have occurred at least 2\n             months prior to enrollment with an onset of disease < 16 years of age:\n\n             \u2022 Arthritis in one or more joints, with or preceded by fever of at least 2 weeks\n             duration that is documented to be daily/quotidian for at least 3 days and accompanied\n             by one or more of the following:\n\n               -  Evanescent non-fixed erythematous rash,\n\n               -  Generalized lymph node enlargement,\n\n               -  Hepatomegaly and/ or splenomegaly,\n\n               -  Serositis\n\n          3. Active systemic disease at the time of baseline visit defined as having 2 or  more of\n             the following:\n\n               -  Documented spiking, intermittent fever (body temperature > 38\u00b0C) for at least 1\n                  day during the screening period and within 1 week before first canakinumab dose,\n\n               -  At least 2 joints with active arthritis (using ACR definition of active joint),\n\n               -  C-reactive protein (CRP) > 30 mg/L (normal range < 10 mg/L),\n\n               -  Rash,\n\n               -  Serositis,\n\n               -  Lymphadenopathy,\n\n               -  Hepatosplenomegaly\n\n          4. Patient's willingness to discontinue anakinra, rilonacept, tocilizumab or other\n             experimental drug under close monitoring\n\n          5. Patients who are scheduled to receive an immunization, according to their local\n             vaccination guidelines, with an inactivated vaccine and willing to participate in the\n             assessment schedule for vaccinated patients\n\n        Key exclusion criteria:\n\n        Cohort 1 and Cohort 2:\n\n          1. Active or recurrent bacterial, fungal or viral infection at the time of enrollment\n\n          2. Underlying metabolic, renal, hepatic, infectious or gastrointestinal conditions which\n             in the opinion of the investigator immunocompromises the patient and/ or places the\n             patient at unacceptable risk for participation in an immunomodulatory therapy.\n\n          3. History of malignancy of any organ system (other than localized basal cell carcinoma\n             of the skin), treated or untreated, within the past 5 years, regardless of whether\n             there is evidence of local recurrence or metastases.\n\n          4. Live vaccinations within 3 months prior to the start of the study.\n\n        Cohort 2:\n\n        The following additional key exclusion criteria apply for Cohort 2.\n\n          1. Presence of moderate to severe impaired renal function\n\n          2. Clinical evidence of liver disease or liver injury as indicated by abnormal liver\n             function tests at screening\n\n          3. History/evidence of macrophage activation syndrome within the previous 6 months\n\n        Other protocol-defined inclusion/exclusion criteria may apply."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "20 Years", 
            "minimum_age": "2 Years"
        }, 
        "enrollment": {
            "#text": "220", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 29, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01676948", 
            "org_study_id": "CACZ885G2402", 
            "secondary_id": "2012-003054-92"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Canakinumab - Cohort 1, 2mg", 
                    "Canakinumab - Cohort 1, 4mg", 
                    "Cohort 1 - canakinumab dose reduction"
                ], 
                "description": "Patients rolling over into this study from CACZ885G2301E1 (Cohort 1) will continue on their established canakinumab dose of either 4 mg/kg SC given every 4 weeks or 2mg/kg SC given every 4 weeks, until eligible for dose reduction.\nCanakinumab-na\u00efve patients", 
                "intervention_name": "Canakinumab - Cohort 1", 
                "intervention_type": "Drug", 
                "other_name": "Canakinumab"
            }, 
            {
                "arm_group_label": [
                    "Canakinumab - Cohort 2, 2mg", 
                    "Canakinumab - Cohort 2, 4mg", 
                    "Cohort 2 - canakinumab dose reduction"
                ], 
                "description": "Patients rolling over into this study from CACZ885G2301E1(Cohort 2) will receive a standard canakinumab dose of 4mg/kg SC given every 4 weeks, until eligible for dose reduction", 
                "intervention_name": "Canakinumab - Cohort 2", 
                "intervention_type": "Drug", 
                "other_name": "canakinumab"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Antibodies, Monoclonal"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "SJIA", 
            "Systemic Juvenile Idiopathic Arthritis", 
            "children", 
            "systemic autoinflammatory disease, ACZ885, canakinumab", 
            "human monoclonal anti-interleukin-1\u03b2 (IL-1 \u03b2) antibody", 
            "childhood immunizations vaccinations"
        ], 
        "lastchanged_date": "March 6, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90027"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40202"
                    }, 
                    "name": "Novartis Investigational Site - University of Lousville"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02111"
                    }, 
                    "name": "Novartis Investigational Site - Tufts New England Medical Center, Department of Allergy"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45229"
                    }, 
                    "name": "Novartis Investigational Site - Children's Hospital Medical Center"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Columbus", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43205"
                    }, 
                    "name": "Novartis Investigational Site - Nationwide Children's Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Portland", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97227"
                    }, 
                    "name": "Novartis Investigational Site - Legacy Emanuel Hospital"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Buenos Aires", 
                        "country": "Argentina"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Vienna", 
                        "country": "Austria"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-78-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Bruxelles", 
                        "country": "Belgium"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Ghent", 
                        "country": "Belgium"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Laeken", 
                        "country": "Belgium"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Leuven", 
                        "country": "Belgium"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-830"
                }, 
                "facility": {
                    "address": {
                        "city": "Curitiba", 
                        "country": "Brazil"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Rio de Janeiro", 
                        "country": "Brazil"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Sao Paulo", 
                        "country": "Brazil"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Vancouver", 
                        "country": "Canada", 
                        "state": "British Columbia"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Halifax", 
                        "country": "Canada", 
                        "state": "Nova Scotia"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1-862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Le Kremlin Bucetre", 
                        "country": "France"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Lyon", 
                        "country": "France"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Paris", 
                        "country": "France"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Strasbourg", 
                        "country": "France"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "=! 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "bam Bamstedt", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Bremen", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Freibourg", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Garmisch-Partenkirch", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Hamburg", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-7780-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Krefeld", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Munster", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Tubingen", 
                        "country": "Germany"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Ampelokipi", 
                        "country": "Greece"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Goudi-Athens", 
                        "country": "Greece"
                    }, 
                    "name": "Novartis Investigational Site"
                }
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Thessaloniki", 
                        "country": "Greece"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Haifa", 
                        "country": "Israel"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Kfar Saba", 
                        "country": "Israel"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Petach-Tikya", 
                        "country": "Israel"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Ramat Gan", 
                        "country": "Israel"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Rehovat", 
                        "country": "Israel"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Firenze", 
                        "country": "Italy"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Genova", 
                        "country": "Italy"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Milano", 
                        "country": "Italy"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Napoli", 
                        "country": "Italy"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-77808300"
                }, 
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Warsawa", 
                        "country": "Poland"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Moscow", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Esplugues (Barcelona)", 
                        "country": "Spain"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Stockholm", 
                        "country": "Sweden"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Ankara", 
                        "country": "Turkey"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Istanbul", 
                        "country": "Turkey"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Izmir", 
                        "country": "Turkey"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Bath", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Liverpool", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Manchester", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Newcastle-upon-Tyne", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Study Director", 
                    "phone": "+1 862-778-8300"
                }, 
                "facility": {
                    "address": {
                        "city": "Oxford", 
                        "country": "United Kingdom"
                    }, 
                    "name": "Novartis Investigational Site"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Argentina", 
                "Austria", 
                "Belgium", 
                "Brazil", 
                "Canada", 
                "France", 
                "Germany", 
                "Greece", 
                "Hungary", 
                "Israel", 
                "Italy", 
                "Netherlands", 
                "Poland", 
                "Russian Federation", 
                "Spain", 
                "Sweden", 
                "Switzerland", 
                "Turkey", 
                "United Kingdom"
            ]
        }, 
        "number_of_arms": "6", 
        "official_title": "An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA)", 
        "overall_contact": {
            "last_name": "Novartis Pharmaceuticals", 
            "phone": "+1 862-778-8300"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Argentina: Ministry of Health", 
                "Austria: Agency for Health and Food Safety", 
                "Belgium:   Federal Agency for Medicinal and Health Products", 
                "Brazil: Ministry of Health", 
                "Canada: Health Canada", 
                "Czech Republic: State Institute for Drug Control", 
                "France: Afssaps - Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9 (Saint-Denis)", 
                "Germany:  Paul-Ehrlich-Institut (PEI)", 
                "Greece:  National Organization for Medicines", 
                "Hungary: National Institute of Pharmacy", 
                "Israel: Ministry of Health", 
                "Italy: Ministry of Health", 
                "Netherlands:  Central Committee on Research Involving Human Subjects                 (CCMO)", 
                "Peru: Ministry of Health", 
                "Poland: Office for Registration of Medicinal Products, Medical Devices and Biocidal Products", 
                "Russia:  Federal Service on Surveillance in Healthcare and Social Development", 
                "Spain: Spanish Agency of Medicines", 
                "Sweden: Medical Products Agency", 
                "Switzerland: Swissmedic", 
                "Turkey: Ministry of Health", 
                "United Kingdom: Medicines and Healthcare Products Regulatory Agency", 
                "United States: Food and Drug Administration"
            ]
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Outcome Measure Description: The long-term safety and tolerability of canakinumab and the retention rate of canakinumab-treated patients will be evaluated by monitoring of serious adverse events and adverse events leading to discontinuation of study drug.", 
            "measure": "Long-term safety and tolerability of canakinumab and the retention rate of canakinumab-treated patients", 
            "safety_issue": "Yes", 
            "time_frame": "Days 1 to 533"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01676948"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "Outcome Measure Description: Patients will be classified into the adapted pediatric ACR categories to characterize their magnitude of efficacy response. JADAS will be derived from physician global assessment, parent/patient global assessment, active joint count and CRP.", 
                "measure": "The percentage of patients who meet the adapted pediatric ACR, its individual components, and the Juvenile Arthritis Disease Activity Score [JADAS] over time", 
                "safety_issue": "No", 
                "time_frame": "Days 1 to 533"
            }, 
            {
                "description": "Patients will be classified into the following 3 categories: \u2265 0.2 mg/kg at end of Part I, those who reach a corticosteroid dose between >0-<0.2 mg/kg and those who reach corticosteroid free regimen.", 
                "measure": "The level of systemic corticosteroid tapering achieved in Part I", 
                "safety_issue": "No", 
                "time_frame": "Day 1 to start of Part II"
            }, 
            {
                "description": "In the canakinumab dose reduction arm, patients will be classified into the following 3 categories: Number of patients who are able to reach 1mg/kg q4wk at the end of Part II, canakinumab free regimen by the end of Part II and those who come back to 2mg/kg q4wk at the end of Part II.\nIn the canakinumab dose interval arm, patients will be classified into the following 3 categories: Number of patients who are able to reach 4mg/kg q12wk at the end of Part II, canakinumab-free regimen by the end of Part II and those who come back to 4mg/kg q8wk at the end of Part II.", 
                "measure": "The level of canakinumab tapering achieved after randomization to the dose reduction arm or dose interval prolongation treatment arm in Part II", 
                "safety_issue": "No", 
                "time_frame": "from start of Part II to Day 533"
            }, 
            {
                "description": "Time to treatment failure (TTF) is defined as time from randomization to the date when the patient's worsened SJIA disease activity requires increasing the doze or shortening the treatment interval of canakinumab or the date the patient is withdrawn from the study due to a safety concern.", 
                "measure": "The time to treatment failure in Part II", 
                "safety_issue": "No", 
                "time_frame": "from  start of Part II to Day 533"
            }
        ], 
        "source": "Novartis", 
        "sponsors": {
            "collaborator": {
                "agency": "PRINTO/PRCSG", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Novartis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}